Roger S. McIntyre, MD | Psychiatrist.com

Educational Activity

Improving Remission Rates in Major Depressive Disorder: A Case-Based Approach

February 21, 2018

Roger S. McIntyre

Educational Activity

Cognitive Impairment in Major Depressive Disorder: A Case Discussion Illustrating Impact, Assessment, and Management

February 21, 2018

Larry Culpepper, Raymond W. Lam, Roger S. McIntyre

Educational Activity

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

December 27, 2017

Roger S. McIntyre

Academic Highlights

Cognitive Impairment in Depression

December 19, 2017

Is cognitive impairment keeping your patients with MDD from achieving full functional recovery? In this Academic Highlights, leading experts in MDD discuss the burden associated with cognitive impairment, effective...

Larry Culpepper, Raymond W. Lam, Roger S. McIntyre

Academic Highlights

Depression With Mixed Features

September 26, 2017

Descriptions of mixed states can be found in the writings of ancient Greek physicians, and the concept continues to be refined. In this CME activity, join experts as they...

Rakesh Jain, Vladimir Maletic, Roger S. McIntyre

Original Research

THINC-it Validation for MDD

August 23, 2017

Cognitive dysfunction greatly affects functional outcome in patients with major depressive disorder, but existing tools to measure cognition in depression are inadequate. Read this article to see if the...

Roger S. McIntyre, Michael W. Best, Christopher R. Bowie, et al

Original Research

Depression and Bone Mineral Density

August 22, 2017

Is bone mineral density related to severity of current symptoms of depression? Read this article to learn if this hitherto-unresolved connection exists.

Rocco D. Hlis, Roger S. McIntyre, Naim M. Maalouf, et al

Article

Florida Medication Guidelines for MDD

June 28, 2017

Do you need concise, pragmatic, evidence-based decision support for treating adults with MDD? In this CME activity, find updated guidelines that address medication choices as well as measurement-based care,...

Roger S. McIntyre, Trisha Suppes, Rajiv Tandon, et al

Review Article

Pharmacogenomic Testing and MDD Outcomes

June 28, 2017

In theory, pharmacogenomic testing in patients with depression can improve clinical outcomes by guiding antidepressant selection and dosing. This review looks at the current evidence to evaluate the clinical...

Joshua D. Rosenblat, Yena Lee, Roger S. McIntyre

Original Research

Vortioxetine and Cognition in Working Patients With MDD

January 25, 2017

Many studies have shown that people with MDD have reduced work productivity, and cognitive symptoms are common. This study looked at whether antidepressant treatment with vortioxetine would improve cognitive...

Roger S. McIntyre, Ioana Florea, Brigitte Tonnoir, et al

Educational Activity

Implementing Appropriate Treatment Strategies for Varying Types of Depression

October 26, 2016

Roger S. McIntyre

Article

Early Optimized Treatment in MDD

September 1, 2016

Delayed depression treatment is associated with poorer clinical outcomes. This review highlights the evidence for a more rapid, individualized treatment approach to improve outcomes for individual patients.

Jeffrey Habert, Martin A. Katzman, Oloruntoba J. Oluboka, et al

« 1 2 3 4 5 … 7 »